Heraeus Acquires Mo-Sci Corporation, ETS Technology Holdings

The Heraeus Group, an international family-owned portfolio company, has acquired Mo-Sci Corporation (Mo-Sci), a world leader in the supply of medical and specialty glass and ETS Technology Holdings LLC (ETS), a provider of wound care technologies. Both companies are located in Rolla, Mo.
 
Mo-Sci was founded by Dr. Delbert Day in 1985 to develop and supply specialty glass and ceramic products for specific market applications. Today, Mo-Sci supplies the medical device industry with glass microspheres, fibers and powders. It also provides sealing glass and test services for the aerospace, automotive and electronics industries. The company was led by Ted Day, Delbert’s son, up until his death in September 2020.

Kimberly Day, owner of Mo-Sci and ETS, said, “Mo-Sci and Heraeus have been in contact for many years and prior to his passing, Ted identified Heraeus as a preferred partner to take Mo-Sci and ETS to the next stage of development. I am glad to carry this vision through to completion.”

Heraeus plans to keep the existing Mo-Sci team and facilities in Rolla.
 
ETS was founded in 2012 to develop and commercialize a novel borate-based bioactive glass technology platform for wound care and hemostasis. ETS received U.S. Food and Drug Administration clearance for its first product, Mirragen, a resorbable synthetic skin substitute, and continues to expand the technology to new applications.
 
The addition of these two new businesses will strengthen the Heraeus healthcare and medical technology portfolio, which includes market leadership in the supply of medical components and devices, the PALACOS orthopadic bone cement line, and other technologies and cutting-edge innovations for the healthcare and medical device industries. Nicolas Guggenheim, president of Business Area Medtech, said, “Across every treatment area, medical technology is changing rapidly. The acquisition of Mo-Sci and ETS gives us new capabilities to help our customers deliver innovative technologies and breakthrough treatments that will improve outcomes and patient care.”
 
The acquisition is expected to close by the end of 2021, pending legal clearance and satisfaction of customary closing conditions.
 
Heraeus, the technology group headquartered in Hanau, Germany, is an international family-owned portfolio company. The company’s roots go back to a family pharmacy started in 1660. Today, the Heraeus group includes businesses in the environmental, electronics, health and industrial applications sectors. In 2020, the FORTUNE Global 500 listed group generated revenues of 31.5 billion euros with approximately 14,800 employees in 40 countries.